News & Events

Latest News

January 25, 2023

Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor

November 29, 2022

Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team

October 19, 2022

ECTRIMS 2022, October 26-28, Amsterdam, The Netherlands

October 18, 2022

Rewind Therapeutics Appoints Irene Knuesel, PhD, as Chief Scientific Officer

September 22, 2021

Rewind Therapeutics appoints Anja Harmeier, PhD, MBA, as Chief Executive Officer

September 2, 2020

Rewind Therapeutics appoints Kees Been as Non-Executive Director

Upcoming Events

August 24, 2022

BIO Europe, October 24-26, Leipzig, Germany

This website uses cookies to ensure you get the best experience on our website. Get more details by clicking on the Button below.